Glutamine synthetase and related protein in the frontal cortex in schizophrenia

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 100, Issue 7, 2000, Pages 51-52

  Tereshkina, E B ^a   Boksha, I S ^a   Savushkina, O K ^a   Burbaeva, G Sh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE AMMONIA LIGASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; ENZYMOLOGY; FRONTAL LOBE; HUMAN; METABOLISM; SCHIZOPHRENIA;

FRONTAL LOBE; GLUTAMATE-AMMONIA LIGASE; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0033651242     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Akbarian S. et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996; 16: 19-30.
2. Burbaeva G.Sh., Boksha I.S., Tereshkina E.B., Savushkina O.K. Biochemical approaches to the brain glutamate metabolism study in schizophrenia. Schizophrenia Res 1999; 36: 1-3: 70.
3. Deakin J.F. et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 1989; 52: 1781-1786.
4. Egan M.F., Weinberger D.R. Neurobiology of schizophrenia. Curr Opin Neurobiol 1997; 7: 5: 701-707.
5. Halberstadt A.L. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 1995; 18: 237-249.
6. Heresco-Levy U., Javitt D.C. The role of NMDA-receptor-mediated neurotransmission in the patophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol 1998; 8: 141-152.
7. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
8. Ohnuma T. et al. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the frontal cortex from normal individuals and patients with schizophrenia. Mol Brain Res 1998; 56: 207-217.
9. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiat 1995; 52: 998-1007.
10. Simpson M.D. et al. Alterations in phencyclidine and sigma hinding sites in schizophrenic brains: effects of disease processes and neuroleptic medication. Schizophrenia Res 1991; 6: 41-48.
11. Tsai G. et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brain. Arch Gen Psychiat 1995; 52: 829-836.